Opening book details…
About this Medicine article
P84.10 The Impact of 3rd-Line ALK Inhibitors in ALK Positive NSCLC in Real-World Data by Moskovitz, M. (author);Dudnik, E. (author);Rotenberg, Y. (author);Popovich-Hadari, N. (author);Wollner, M. (author);Zer, A. (author);Gottfried, M. (author);Mishaeli, M. (author);Keren-Rosenberg, S. (author);Onn, A. (author);Urban, D. (author);Peled, N. (author);Maimon, N. (author);Bar, J. (author) is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Moskovitz, M. (author);Dudnik, E. (author);Rotenberg, Y. (author);Popovich-Hadari, N. (author);Wollner, M. (author);Zer, A. (author);Gottfried, M. (author);Mishaeli, M. (author);Keren-Rosenberg, S. (author);Onn, A. (author);Urban, D. (author);Peled, N. (author);Maimon, N. (author);Bar, J. (author)
- Publisher
- Elsevier BV
- Published
- 2021
- Field
- Medicine (Health Sciences)